Peroxisome proliferator-activated receptor-γ polymorphism (rs1801282) is associated with obesity in Egyptian patients with coronary artery disease and type 2 diabetes mellitus
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 15 (2) , 409-414
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptor Pathway Gene Polymorphism Associated With Extent of Coronary Artery Disease in Patients With Type 2 Diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes TrialCirculation, 2011
- Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han populationOncology Letters, 2011
- PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitusCardiovascular Diabetology, 2010
- Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator‐activated receptor gammaEuropean Journal of Clinical Investigation, 2008
- Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous populationActa Diabetologica, 2007
- Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004Hypertension, 2007
- The peroxisome proliferator activated receptorφ2 (PPARφ2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patientsDiabetes & Metabolism, 2005
- PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoterFEBS Letters, 1998
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990